About Select Medical Holdings Corporation (NYSE:SEM)
Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company's segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. The Concentra segment consists of medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics (CBOCs) that deliver occupational medicine, physical therapy, veteran's healthcare, and consumer health services. As of December 31, 2016, the Company had operations in 46 states and the District of Columbia.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Healthcare Facilities & Services
- Sub-Industry: Health Care Facilities
- Symbol: NYSE:SEM
- CUSIP: 81619Q10
- Web: www.selectmedicalcorp.com
- Market Cap: $2.45 billion
- Outstanding Shares: 132,936,000
- 50 Day Moving Avg: $18.37
- 200 Day Moving Avg: $15.86
- 52 Week Range: $10.20 - $19.60
Sales & Book Value:
- Trailing P/E Ratio: 28.21
- Foreward P/E Ratio: 18.22
- P/E Growth: 1.37
- Annual Revenue: $4.26 billion
- Price / Sales: 0.57
- Book Value: $6.38 per share
- Price / Book: 2.88
- EBITDA: $474.8 million
- Net Margins: 1.95%
- Return on Equity: 9.61%
- Return on Assets: 1.84%
- Debt-to-Equity Ratio: 2.90%
- Current Ratio: 1.53%
- Quick Ratio: 1.53%
- Average Volume: 967,843 shs.
- Beta: 1.42
- Short Ratio: 10.2
Frequently Asked Questions for Select Medical Holdings Corporation (NYSE:SEM)
What is Select Medical Holdings Corporation's stock symbol?
Select Medical Holdings Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "SEM."
How were Select Medical Holdings Corporation's earnings last quarter?
Select Medical Holdings Corporation (NYSE:SEM) issued its earnings results on Thursday, August, 3rd. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.25 by $0.07. The company earned $1.12 billion during the quarter, compared to analyst estimates of $1.13 billion. Select Medical Holdings Corporation had a return on equity of 9.61% and a net margin of 1.95%. The business's revenue was up 2.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.23 EPS. View Select Medical Holdings Corporation's Earnings History.
When will Select Medical Holdings Corporation make its next earnings announcement?
What guidance has Select Medical Holdings Corporation issued on next quarter's earnings?
Select Medical Holdings Corporation updated its FY17 earnings guidance on Thursday, August, 3rd. The company provided earnings per share (EPS) guidance of $0.78-0.96 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.87. The company issued revenue guidance of $4.4-4.6 billion, compared to the consensus revenue estimate of $4.46 billion.
Where is Select Medical Holdings Corporation's stock going? Where will Select Medical Holdings Corporation's stock price be in 2017?
6 equities research analysts have issued 1-year price targets for Select Medical Holdings Corporation's stock. Their forecasts range from $12.00 to $22.00. On average, they expect Select Medical Holdings Corporation's stock price to reach $18.80 in the next year. View Analyst Ratings for Select Medical Holdings Corporation.
Who are some of Select Medical Holdings Corporation's key competitors?
Some companies that are related to Select Medical Holdings Corporation include HealthSouth Corporation (HLS), Mednax (MD), Acadia Healthcare Company (ACHC), Chemed Corp. (CHE), LifePoint Health (LPNT), Udg Healthcare PLC (UDG), HMS Holdings Corp (HMSY), Tenet Healthcare Corporation (THC), China Cord Blood Corporation (CO), HealthStream (HSTM), The Providence Service Corporation (PRSC), Community Health Systems (CYH), Kindred Healthcare (KND), Georgia Healthcare Group PLC (GHG), American Renal Associates Holdings (ARA), Cambian Group PLC (CMBN), Concord Medical Services Holdings Limited (CCM) and Nobilis Health Corp (HLTH).
Who are Select Medical Holdings Corporation's key executives?
Select Medical Holdings Corporation's management team includes the folowing people:
- Robert A. Ortenzio, Executive Chairman of the Board, Co-Founder
- David S. Chernow, President, Chief Executive Officer
- Rocco A. Ortenzio, Vice Chairman of the Board, Co-Founder
- Martin F. Jackson, Chief Financial Officer, Executive Vice President
- John A. Saich, Executive Vice President, Chief Human Resources Officer
- Michael E. Tarvin, Executive Vice President, General Counsel, Secretary
- Scott A. Romberger, Senior Vice President, Chief Accounting Officer, Controller
- Robert G. Breighner Jr., Vice President - Compliance and Audit Services, Corporate Compliance Officer
- Russell L. Carson, Lead Independent Director
- William H. Frist M.D., Director
Who owns Select Medical Holdings Corporation stock?
Select Medical Holdings Corporation's stock is owned by a number of of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (3.40%), Smith Graham & Co. Investment Advisors LP (0.51%), Shell Asset Management Co. (0.11%), Nationwide Fund Advisors (0.06%), Strs Ohio (0.05%) and Eqis Capital Management Inc. (0.01%). Company insiders that own Select Medical Holdings Corporation stock include David S Chernow, James E Dalton Jr, Michael E Tarvin and Scott A Romberger. View Institutional Ownership Trends for Select Medical Holdings Corporation.
Who sold Select Medical Holdings Corporation stock? Who is selling Select Medical Holdings Corporation stock?
Select Medical Holdings Corporation's stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Strs Ohio, Smith Graham & Co. Investment Advisors LP and Nationwide Fund Advisors. Company insiders that have sold Select Medical Holdings Corporation stock in the last year include David S Chernow, Michael E Tarvin and Scott A Romberger. View Insider Buying and Selling for Select Medical Holdings Corporation.
Who bought Select Medical Holdings Corporation stock? Who is buying Select Medical Holdings Corporation stock?
How do I buy Select Medical Holdings Corporation stock?
Shares of Select Medical Holdings Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Select Medical Holdings Corporation's stock price today?
MarketBeat Community Rating for Select Medical Holdings Corporation (NYSE SEM)MarketBeat's community ratings are surveys of what our community members think about Select Medical Holdings Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Select Medical Holdings Corporation stock can currently be purchased for approximately $18.40.
Consensus Ratings for Select Medical Holdings Corporation (NYSE:SEM) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 2 Hold Ratings, 3 Buy Ratings|
|Consensus Rating:||Hold (Score: 2.33)|
|Consensus Price Target: ||$18.80 (2.17% upside)|Consensus Price Target History for Select Medical Holdings Corporation (NYSE:SEM)
Analysts' Ratings History for Select Medical Holdings Corporation (NYSE:SEM)
(Data available from 10/24/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|10/17/2017||Robert W. Baird||Reiterated Rating||Buy||$21.00||N/A|
|10/13/2017||Royal Bank Of Canada||Reiterated Rating||Buy||$19.00||N/A|
|8/7/2017||JMP Securities||Boost Price Target||Market Underperform||$10.00 -> $12.00||High|
|8/7/2017||Deutsche Bank AG||Boost Price Target||Hold||$20.00 -> $22.00||Low|
|8/7/2017||Benchmark Co.||Boost Price Target||Buy -> Buy||$17.00 -> $20.00||High|
|1/30/2017||Wells Fargo & Company||Downgrade||Outperform -> Market Perform||N/A|
Earnings History for Select Medical Holdings Corporation (NYSE:SEM)Earnings History by Quarter for Select Medical Holdings Corporation (NYSE SEM)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/3/2017||Q2 2017||$0.25||$0.32||$1.13 billion||$1.12 billion||View||Listen|
|2/23/2017||Q4 2016||$0.10||$0.12||$1.05 billion||$1.05 billion||View||N/A|
|11/3/2016||Q316||$0.15||$0.06||$1.05 billion||$1.05 billion||View||N/A|
|8/4/2016||Q216||$0.24||$0.23||$1.10 billion||$1.10 billion||View||N/A|
|5/5/2016||Q116||$0.23||$0.23||$1.06 billion||$1.09 billion||View||N/A|
|2/25/2016||Q415||$0.17||$0.22||$1.01 billion||$1.04 billion||View||Listen|
|10/29/2015||Q315||$0.20||$0.22||$972.24 million||$1.02 billion||View||Listen|
|8/6/2015||Q215||$0.25||$0.28||$809.23 million||$887.07 million||View||N/A|
|4/30/2015||Q115||$0.23||$0.27||$783.58 million||$795.30 million||View||N/A|
|2/19/2015||Q414||$0.20||$0.20||$768.62 million||$771.60 million||View||N/A|
|10/30/2014||Q314||$0.20||$0.20||$750.00 million||$758.10 million||View||N/A|
|8/7/2014||Q214||$0.27||$0.27||$777.16 million||$772.80 million||View||N/A|
|5/1/2014||Q114||$0.24||$0.25||$760.50 million||$762.60 million||View||Listen|
|2/20/2014||Q413||$0.20||$0.21||$735.00 million||$746.20 million||View||Listen|
|11/1/2013||Q313||$0.19||$0.20||$723.10 million||$722.80 million||View||Listen|
|8/8/2013||Q2 2013||$0.24||$0.20||$752.84 million||$756.70 million||View||Listen|
|5/2/2013||Q1 2013||$0.27||$0.25||$760.59 million||$749.95 million||View||Listen|
|2/21/2013||Q4 2012||$0.25||$0.28||$747.01 million||$741.10 million||View||Listen|
|11/1/2012||Q312||$0.21||$0.20||$727.70 million||$713.70 million||View||N/A|
Earnings Estimates for Select Medical Holdings Corporation (NYSE:SEM)
Current Year EPS Consensus Estimate: $0.89 EPS
Next Year EPS Consensus Estimate: $1.01 EPS
Current Dividend Information for Select Medical Holdings Corporation (NYSE:SEM)
|Most Recent Dividend:||3/11/2015|
|Dividend Growth:||0.00% (3 Year Average)|
|Payout Ratio:||0.00% (Trailing 12 Months of Earnings) |
0.00% (Based on This Year's Estimates)
0.00% (Based on Next Year's Estimates)
Dividend History by Quarter for Select Medical Holdings Corporation (NYSE SEM)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Select Medical Holdings Corporation (NYSE:SEM)
Insider Ownership Percentage: 19.93%Insider Trades by Quarter for Select Medical Holdings Corporation (NYSE:SEM)
Institutional Ownership Percentage: 79.02%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/14/2017||David S Chernow||Insider||Sell||133,025||$17.85||$2,374,496.25|| |
|6/28/2017||Michael E Tarvin||Insider||Sell||35,000||$15.25||$533,750.00|| |
|6/27/2017||Michael E Tarvin||EVP||Sell||7,948||$15.25||$121,207.00|| |
|6/26/2017||Michael E Tarvin||EVP||Sell||4,500||$15.25||$68,625.00|| |
|6/12/2017||Scott A Romberger||Insider||Sell||3,127||$14.37||$44,934.99|| |
|5/8/2017||David S Chernow||Insider||Sell||116,050||$14.01||$1,625,860.50|| |
|2/28/2017||Scott A Romberger||Insider||Sell||4,000||$14.52||$58,080.00|| |
|9/30/2016||David S Chernow||Insider||Sell||50,000||$13.51||$675,500.00|| |
|9/7/2016||David S Chernow||Insider||Sell||90,164||$12.11||$1,091,886.04|| |
|8/30/2016||David S Chernow||Insider||Sell||1,300||$12.00||$15,600.00|| |
|8/8/2016||David S Chernow||Insider||Sell||8,536||$12.13||$103,541.68|| |
|5/23/2016||James E Dalton Jr||Director||Sell||12,000||$12.37||$148,440.00|| |
|9/10/2015||William H Frist||Director||Buy||8,100||$12.32||$99,792.00|| |
|7/1/2015||David S Chernow||CEO||Sell||39,025||$16.38||$639,229.50|| |
|6/29/2015||North Tide Capital, Llc||Major Shareholder||Sell||450,000||$16.51||$7,429,500.00|| |
|6/25/2015||Scott A Romberger||SVP||Sell||10,000||$16.95||$169,500.00|| |
|6/19/2015||Robert G Breighner Jr||VP||Sell||10,000||$16.64||$166,400.00|| |
|3/10/2015||North Tide Capital, Llc||Major Shareholder||Sell||500,000||$13.27||$6,635,000.00|| |
|12/29/2014||James J Talalai||COO||Sell||2,800||$15.00||$42,000.00|| |
|12/22/2014||Bryan C Cressey||Director||Sell||18,500||$14.69||$271,765.00|| |
|11/18/2014||Leopold Swergold||Director||Sell||6,267||$13.75||$86,171.25|| |
|10/3/2014||David S Chernow||CEO||Sell||100,000||$12.07||$1,207,000.00|| |
|9/22/2014||Russell L Carson||Director||Sell||304,272||$13.02||$3,961,621.44|| |
|9/17/2014||Russell L Carson||Director||Sell||443,175||$13.07||$5,792,297.25|| |
|9/16/2014||Russell L Carson||Director||Sell||105,714||$13.04||$1,378,510.56|| |
|9/15/2014||Russell L Carson||Director||Sell||166,416||$13.12||$2,183,377.92|| |
|9/12/2014||Russell L Carson||Director||Sell||1,012,016||$13.35||$13,510,413.60|| |
|9/11/2014||Thomas Scully||Director||Sell||14,752||$13.45||$198,414.40|| |
|9/10/2014||Thomas Scully||Director||Sell||7,207||$13.44||$96,862.08|| |
|9/3/2014||Russell L Carson||Director||Sell||13,798||$14.00||$193,172.00|| |
|8/29/2014||Thomas Scully||Director||Sell||12,686||$14.06||$178,365.16|| |
|8/28/2014||Russell L Carson||Director||Sell||91,983||$14.05||$1,292,361.15|| |
|8/27/2014||Russell L Carson||Director||Sell||164,340||$14.08||$2,313,907.20|| |
|8/26/2014||Thomas Scully||Director||Sell||8,459||$14.03||$118,679.77|| |
|8/21/2014||Thomas Scully||Director||Sell||3,106||$14.01||$43,515.06|| |
|8/19/2014||Thomas Scully||Director||Sell||8,533||$14.08||$120,144.64|| |
|8/14/2014||Thomas Scully||Director||Sell||9,814||$14.07||$138,082.98|| |
|7/30/2014||Rocco A Ortenzio||Chairman||Sell||168,800||$16.02||$2,704,176.00|| |
|6/6/2014||Robert G Breighner Jr||VP||Sell||10,000||$15.51||$155,100.00|| |
|6/6/2014||Rocco A Ortenzio||Chairman||Sell||234,179||$15.21||$3,561,862.59|| |
|6/5/2014||Thomas Scully||Director||Sell||213,556||$13.49||$2,880,870.44|| |
|6/4/2014||Rocco A Ortenzio||Chairman||Sell||431,821||$14.93||$6,447,087.53|| |
|5/5/2014||Scott Romberger||SVP||Sell||75,000||$13.90||$1,042,500.00|| |
|3/13/2014||Carson Anderson & Stowe Welsh||major shareholder||Sell||9,571,108||$10.95||$104,803,632.60|| |
|3/5/2014||Scott Romberger||SVP||Sell||18,000||$11.95||$215,100.00|| |
|3/4/2014||Michael Tarvin||EVP||Sell||97,970||$11.19||$1,096,284.30|| |
|2/10/2014||Carson Anderson & Stowe Welsh||major shareholder||Sell||4,594,133||$10.94||$50,259,815.02|| |
|1/9/2014||Robert Ortenzio||Chairman||Sell||1,564,345||$11.20||$17,520,664.00|| |
|1/6/2014||Robert Ortenzio||Chairman||Sell||435,655||$11.25||$4,901,118.75|| |
|12/20/2013||Carson Anderson & Stowe Welsh||major shareholder||Sell||314,268||$10.63||$3,340,668.84|| |
|12/19/2013||Carson Anderson & Stowe Welsh||major shareholder||Sell||867,764||$10.25||$8,894,581.00|| |
|12/11/2013||Carson Anderson & Stowe Welsh||major shareholder||Sell||981,824||$9.38||$9,209,509.12|| |
|12/9/2013||Carson Anderson & Stowe Welsh||major shareholder||Sell||574,447||$8.56||$4,917,266.32|| |
|12/4/2013||Carson Anderson & Stowe Welsh||major shareholder||Sell||655,047||$8.56||$5,607,202.32|| |
|11/22/2013||Carson Anderson & Stowe Welsh||major shareholder||Sell||296,144||$8.54||$2,529,069.76|| |
|11/19/2013||Carson Anderson & Stowe Welsh||major shareholder||Sell||255,532||$8.58||$2,192,464.56|| |
|11/14/2013||Carson Anderson & Stowe Welsh||major shareholder||Sell||355,872||$8.49||$3,021,353.28|| |
|8/22/2012||David S Chernow||President||Sell||14,631||$10.35||$151,430.85|| |
Headline Trends for Select Medical Holdings Corporation (NYSE:SEM)
Latest Headlines for Select Medical Holdings Corporation (NYSE:SEM)
Loading headlines, please wait.
Select Medical Holdings Corporation (SEM) Chart for Tuesday, October, 24, 2017